1-7 of 7
Leo J. Schouten
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A62: Clinical translation of liquid biopsy DNA methylation biomarkers: Lessons from two systematic reviews

Kim Lommen, Zheng Feng, Cary J.G. Oberije, Alouisa J. P. van de Wetering, Selena Odeh, Alexander Koch, Maureen J. B. Aarts, Joep G. van Roermund, Leo J. Schouten, Egbert Oosterwijk, Nathalie Vaes, Ad A. M. Masclee, Beatriz Carvalho, Gerrit A. Meijer, Maurice P. Zeegers, James G. Herman, Vivianne C. Tjan-Heijnen, Veerle Melotte, Manon van Engeland, Kim Smits
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11_Supplement): A62.
https://doi.org/10.1158/1557-3265.LiqBiop20-A62
Published: 01 June 2020
View article titled, Abstract A62: Clinical translation of liquid biopsy DNA methylation biomarkers: Lessons from two systematic reviews
Journal Articles

A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients

Iris J.H. van Vlodrop, Sophie C. Joosten, Tim De Meyer, Kim M. Smits, Leander Van Neste, Veerle Melotte, Marcella M.L.L. Baldewijns, Leo J. Schouten, Piet A. van den Brandt, Jana Jeschke, Joo Mi Yi, Kornel E. Schuebel, Nita Ahuja, James G. Herman, Maureen J. Aarts, Fred T. Bosman, Wim Van Criekinge, Manon van Engeland
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (8): 2006–2018.
https://doi.org/10.1158/1078-0432.CCR-16-1236
Published: 13 April 2017
View article titled, A Four-Gene Promoter Methylation Marker Panel Consisting of <em>GREM1, NEURL, LAD1,</em> and <em>NEFH</em> Predicts Survival of Clear Cell Renal Cell Cancer Patients
Open the PDF for A Four-Gene Promoter Methylation Marker Panel Consisting of <em>GREM1, NEURL, LAD1,</em> and <em>NEFH</em> Predicts Survival of Clear Cell Renal Cell Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Abstract AS10: Ovarian cancer risk factor associations by tumor aggressiveness in the ovarian cancer cohort consortium (OC3)

Shelley S. Tworoger, Elizabeth M. Poole, Alan A. Arslan, Lesley M. Butler, Victoria Kirsh, James V. Lacey, Jr., I-Min Lee, Alpa V. Patel, Kim Robien, Thomas Rohan, Dale P. Sandler, Leo J. Schouten, V. Wendy Setiawan, Kala Visvanathan, Elisabete Weiderpass, Emily White, Nicolas Wentzensen, for the OC3
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16_Supplement): AS10.
https://doi.org/10.1158/1557-3265.OVCASYMP14-AS10
Published: 15 August 2015
View article titled, Abstract AS10: Ovarian cancer risk factor associations by tumor aggressiveness in the ovarian cancer cohort consortium (OC3)
Journal Articles

Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome

Ivette A.G. Deckers, Leo J. Schouten, Leander Van Neste, Iris J.H. van Vlodrop, Patricia M.M.B. Soetekouw, Marcella M.L.L. Baldewijns, Jana Jeschke, Nita Ahuja, James G. Herman, Piet A. van den Brandt, Manon van Engeland
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (15): 3492–3500.
https://doi.org/10.1158/1078-0432.CCR-14-2049
Published: 02 August 2015
View article titled, Promoter Methylation of <em>CDO1</em> Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome
Open the PDF for Promoter Methylation of <em>CDO1</em> Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome in another window
Includes: Supplementary data
Journal Articles

KRAS-LCS6 Genotype as a Prognostic Marker in Early-Stage CRC–Response

Kim M. Smits, Trupti Paranjape, Sunitha Nallur, Kim A.D. Wouters, Matty P. Weijenberg, Leo J. Schouten, Piet A. van den Brandt, Fred T. Bosman, Joanne B. Weidhaas, Manon van Engeland
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (12): 3489.
https://doi.org/10.1158/1078-0432.CCR-12-1023
Published: 14 June 2012
View article titled, KRAS-LCS6 Genotype as a Prognostic Marker in Early-Stage CRC–Response
Open the PDF for KRAS-LCS6 Genotype as a Prognostic Marker in Early-Stage CRC–Response in another window
Journal Articles

A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer

Kim M. Smits, Trupti Paranjape, Sunitha Nallur, Kim A.D. Wouters, Matty P. Weijenberg, Leo J. Schouten, Piet A. van den Brandt, Fred T. Bosman, Joanne B. Weidhaas, Manon van Engeland
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7723–7731.
https://doi.org/10.1158/1078-0432.CCR-11-0990
Published: 18 December 2011
View article titled, A <em>Let-7</em> MicroRNA SNP in the <em>KRAS</em> 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
Open the PDF for A <em>Let-7</em> MicroRNA SNP in the <em>KRAS</em> 3′UTR Is Prognostic in Early-Stage Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Genetic and Epigenetic Alterations in the von Hippel-Lindau Gene: the Influence on Renal Cancer Prognosis

Kim M. Smits, Leo J. Schouten, Boukje A.C. van Dijk, Christina A. Hulsbergen-van de Kaa, Kim A.D. Wouters, Egbert Oosterwijk, Manon van Engeland, Piet A. van den Brandt
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 782–787.
https://doi.org/10.1158/1078-0432.CCR-07-1753
Published: 01 February 2008
View article titled, Genetic and Epigenetic Alterations in the von Hippel-Lindau Gene: the Influence on Renal Cancer Prognosis
Open the PDF for Genetic and Epigenetic Alterations in the von Hippel-Lindau Gene: the Influence on Renal Cancer Prognosis in another window